Evidence map›Paper›PMID 37995368›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2023

[Treatment of cardiogenic shock due to right ventricular involvement].

Luis Efrén Santos-Martínez, Gian-Manuel Jiménez-Rodríguez, Jorge Sánchez-Nieto, Sergio Ortiz-Obregón, Diana Romero-Zertuche, Luis-Antonio Moreno-Ruiz

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Luis Efrén Santos-MartínezSecretaría de Salud, Instituto Nacional de Cardiología "Ignacio Chávez", Departamento de Cuidados Intensivos Posquirúrgicos Cardiovasculares. Ciudad de México, México.ORCID 0000-0002-2866-3047
Gian-Manuel Jiménez-RodríguezSecretaría de Salud, Instituto Nacional de Cardiología "Ignacio Chávez", Departamento de Cuidados Intensivos Posquirúrgicos Cardiovasculares. Ciudad de México, México.ORCID 0000-0003-3275-7115
Jorge Sánchez-NietoSecretaría de Salud, Instituto Nacional de Cardiología "Ignacio Chávez", Departamento de Cuidados Intensivos Posquirúrgicos Cardiovasculares. Ciudad de México, México.ORCID 0000-0002-1141-4992
Sergio Ortiz-ObregónInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Departamento de Cuidados Intensivos Posquirúrgicos Cardiovasculares. Ciudad de México, México.ORCID 0000-0003-2893-8263
Diana Romero-ZertucheInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Departamento de Cuidados Intensivos Posquirúrgicos Cardiovasculares. Ciudad de México, México.ORCID 0000-0001-8622-9110
Luis-Antonio Moreno-RuizInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Departamento de Cardiología. Ciudad de México, México.ORCID 0000-0001-5339-3504
Instituto Nacional de Cardiología · MXMexican Social Security Institute · MXCentro Medico Nacional Siglo XXI · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The right ventricle is susceptible to changes in preload, afterload, and contractility. The answer is its dilation with dysfunction/acute failure; filling is limited to the left ventricle and cardiac output. Systemic venous congestion is retrograde to the right heart, it is involved in the genesis of cardiogenic shock due to right ventricle involvement. This form of shock is less well known than that which occurs due to left ventricular failure, therefore, treatment may differ. Once the primary treatment has been carried out, since no response is obtained, supportive treatment aimed at ventricular pathophysiology will be the next option. It is suggested to evaluate the preload for the reasoned indication of liquids, diuretics or even ultrafiltration. Restore or maintain heart rate and sinus rhythm, treat symptomatic bradycardia, arrhythmias that make patients unstable, use of temporary pacing or cardioversion procedures. Improving contractility and vasomotility, using vasopressors and inotropes, alone or in combination, the objective will be to improve right coronary perfusion pressure. Balance the effect of drugs and maneuvers on preload and/or afterload, such as mechanical ventilation, atrial septostomy and pulmonary vasodilators. And the increasing utility of mechanical support of the circulation that has become a useful tool to preserve/restore right heart function.

Indexed as

Heart FailureShock, CardiogenicCardiac OutputHeart VentriclesHumansRespiration, ArtificialChoque CardiogénicoEmbolia PulmonarExtracorporeal Membrane OxygenationFalla CardiacaHeart FailureInfarto del MiocardioMyocardial InfarctionOxigenador de Membrana ExtracorpóreaPulmonary EmbolismShock, Cardiogenic

Identifiers

PMID37995368
PMCPMC10729689
OpenAlexW4388982517

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.